IPO Update | Shenzhen Forms Syntron Information (300468.SZ) and Zhenqu Technology's Planned Hong Kong IPO Applications Accepted by China Securities Regulatory Commission

Stock News01-20

Recently, the China Securities Regulatory Commission (CSRC) released its filing status table for domestic companies seeking overseas securities issuance and listing (covering initial public offerings and full circulation) as of January 16, 2026. Among the updates, the IPO application materials for Shenzhen Forms Syntron Information Co.,Ltd. (300468.SZ) and Zhenqu Technology's planned Hong Kong listing have been accepted by the CSRC. Separately, the filing status for Jingze Biotech's intended Hong Kong IPO is listed as requiring supplementary materials. Furthermore, the application for a full share circulation by L&L Biopharma-B (09887) has been received by the regulator. The full circulation filing for Lingbao Gold (03330) currently holds a status of awaiting additional materials.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment